To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreSyncona Share Price | |
---|---|
Price | 123.00 |
Bid | 122.20 |
Ask | 122.80 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 123.00 |
Currency | GBX |
---|---|
Issue Country | GG |
Shares in Issue | 655.62m |
Market Capitalisation | £806.41m |
Market Size | 10,000 |
52 Week High | 162.20 |
52 Week High Date | 24-May-2023 |
52 Week Low | 105.00 |
52 Week Low Date | 28-Sep-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -14.6778 |
Earnings | -8.38 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
28-Mar-24 | 17:53:56 | 123.012 | 55 | Unknown* | 122.20 | 122.80 | 67.66 | O Ordinary Was reported as OTC |
28-Mar-24 | 16:37:13 | 123.00 | 13,996 | Buy* | 122.20 | 122.80 | 17.22k | O Ordinary |
28-Mar-24 | 16:35:07 | 123.00 | 141,576 | Buy* | 122.20 | 122.80 | 174.14k | UT Uncrossing Trade |
28-Mar-24 | 16:29:42 | 122.20 | 216 | Sell* | 122.20 | 122.80 | 263.95 | A Automatic Execution |
28-Mar-24 | 16:28:48 | 122.80 | 4 | Buy* | 122.20 | 122.80 | 4.91 | O Ordinary Trade was executed as an SI |
28-Mar-24 | 16:13:25 | 122.3861 | 22,280 | Sell* | 122.20 | 123.20 | 27.27k | O Ordinary |
28-Mar-24 | 16:10:29 | 122.88 | 2,000 | Buy* | 122.20 | 123.20 | 2,458 | O Ordinary |
28-Mar-24 | 16:02:33 | 122.20 | 2 | Unknown* | 122.20 | 123.20 | 2.44 | O Ordinary Trade was executed as an SI |
28-Mar-24 | 15:47:35 | 122.20 | 4 | Sell* | 122.20 | 123.20 | 4.89 | A Automatic Execution |
28-Mar-24 | 15:47:00 | 122.8775 | 3,842 | Buy* | 122.20 | 123.20 | 4,721 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
09-Mar-22 | 09-Mar-22 | Buy | Robert Hutchinson held the position of Independent Non-Executive Director at the time of this trade.Robert Hutchinson | 171.80 | GBX | 26,000 | 94,827 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 222.12 | GBX | 639,885 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 223.88 | GBX | 3,222,943 | 2,000,000 |
12-May-21 | 11-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 202.05 | GBX | 2,137,172 | 2,000,000 |
06-Apr-21 | 01-Apr-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 250.01 | GBX | 317,961 | 2,000,000 |
We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients